Biotech | April 03, 2026
Biocon Foundation, BeST Cluster and NCBS launch first BioWISE Cohort for postgraduate women students
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
The decision is based on the phase 3 DESTINY-Breast11 trial
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
As Tracky launches integrated health solution
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
Call it a major breakthrough for diagnostic imaging
The global, first-in-human, open-label trial will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of TRI-611
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
The Phase 2 envisionGI study is testing deudomperidone, an experimental drug aimed at treating idiopathic gastroparesis
Subscribe To Our Newsletter & Stay Updated
